FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

30765911000001103: Erastig 13.3mg/24hours transdermal patches (Teva UK Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 14-Oct 2015. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
94159601000001117 Erastig 13.3mg/24hours transdermal patches (Teva UK Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
94159701000001110 Erastig 13.3mg/24hours transdermal patches (Teva UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Erastig 13.3mg/24hours transdermal patches (Teva UK Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Erastig 13.3mg/24hours transdermal patches (Teva UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Erastig 13.3mg/24hours transdermal patches (Teva UK Ltd) Is a Rivastigmine 13.3mg/24hours transdermal patches true Inferred relationship Existential restriction modifier
Erastig 13.3mg/24hours transdermal patches (Teva UK Ltd) Has active ingredient Rivastigmine true Inferred relationship Existential restriction modifier
Erastig 13.3mg/24hours transdermal patches (Teva UK Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Erastig 13.3mg/24hours transdermal patches (Teva UK Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Erastig 13.3mg/24hours transdermal patches (Teva UK Ltd) Has specific active ingredient Rivastigmine true Inferred relationship Existential restriction modifier
Erastig 13.3mg/24hours transdermal patches (Teva UK Ltd) Has dispensed dose form Prolonged-release transdermal patch true Inferred relationship Existential restriction modifier
Erastig 13.3mg/24hours transdermal patches (Teva UK Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Erastig 13.3mg/24hours transdermal patches (Teva UK Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Erastig 13.3mg/24hours transdermal patches (Teva UK Ltd) Is a Rivatev true Inferred relationship Existential restriction modifier
Erastig 13.3mg/24hours transdermal patches (Teva UK Ltd) Has manufactured dose form Prolonged-release transdermal patch true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Erastig 13.3mg/24hours transdermal patches (Teva UK Ltd) 30 patch Has AMP True Erastig 13.3mg/24hours transdermal patches (Teva UK Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start